Aromatase is a cytochrome P-450 enzyme complex responsible for the conversion of the 4-en-3-one androgens, androst-4-ene-3,17-dione (AD) and testosterone, into estrogens, estrone and estradiol. [1] [2] [3] Aromatization of the androgens is thought to proceed through three sequential oxygenations at the C-19 position, respectively. [4] [5] [6] In the third step, the angular methyl group at C-19 and 1b,2b-hydrogens are eliminated to result in the aromatization of the A-ring of the androgen molecule to form estrogen. Inhibitors of aromatase are valuable as therapeutic agents in the treatment of the advance breast cancer.
Structure-activity studies on aromatase inhibitors [8] [9] [10] [11] [12] [13] [14] and a recent structural prediction of aromatase by modeling 15, 16) indicated the existence of a hydrophobic binding pocket extending roughly in the plane of substrate AD from the position that would be occupied by its C 4 , 8,9) C 6 10,11) and C 7 [12] [13] [14] atoms. On the other hand, in the course of studies on structure-activity relationships of series of 3-deoxy androgens, androst-4-en-17-one (1) 17) and its 5-ene isomer 4, 18) and their 19-hydroxy analogs 2 19) and 5, 18) we found that 4b,19-dihydroxy-5-ene steroid 6 20) is one of the most powerful competitive inhibitor of aromatase among the steroidal compounds reported so far (Fig. 1 ). This finding indicates that the polar 4b,19-diol moiety of 3-deoxy compound 6 can be torelated in the pocket of the active site of aromatase. Thus, diol 6 would play an important role in not only the development of a powerful aromatase inhibitor but also understanding the spacial and electronical nature of the active site.
Compound 6 was previously synthesized from 4b-acetoxyandrost-5-en-17-one (7) in four steps through hypoiodite oxidation of 5a-bromo-6b-ol intermediate, giving 5a-bromo-6b,19-epoxide, as a key reaction. 21) We report here the alternate, improved synthesis of diol 6 suitable for a gram-order scale synthesis along with molecular modeling of this compound with the PM3 method for understanding its three dimensional structure.
Results and Desucussion
Synthetic sequence employed in this study involves an acid-catalyzed trans-diaxial cleavage of an epoxy moiety of 4,5-epoxy steroids 9 and 10 as a key reaction for the introduction of a 4b-hydroxy group to a steroid nucleus (Chart 1). Treatment of 19-(tert-butyldimethylsilyloxy)androst-4-en-17-one (8), previously synthesized, 19) with m-chloroperbenzoic acid (MCPBA) in CH 2 Cl 2 gave a 1.4 : 1 mixture of 4a,5a-epoxide 9 and its 4b,5b-isomer 10 in 90% yield. The configuration of the epoxy ring was established according to the 1 H-NMR spectroscopic data of 4a,5a-and 4b,5b-epoxy steroids having a 19-methyl group 4a,5a-Epoxide 9 and the b-isomer 10 were separately treated with diluted HClO 4 in dioxane produced the kinetic controlled product trans-axial diol 4b,5a-diol 11, in 75% and 79% yields where the trans-equatorial diol product, 4a,5b-diol 12, was also obtained as a minor product in 3 and 7% yields, respectively. Reaction of 4b-acetoxy-5a-ol 13, obtained by acetylation of steroid 11 with acetic anhydride and pyridine, with SOCl 2 gave the dehydrated product in a trans-diaxial manner, 4b-acetoxy-5-ene steroid 14, in a good yield. An axial acetoxy group at C-4b prevented production of 4-ene analog of compound 14. Hydrolysis of diacetate 14 with K 2 CO 3 in aqueous MeOH gave 4b,19-diol 6.
In a sequence developed in this study, chromatographic separation of the intermediate is not essential in each step. This fact along with a higher yield of diol 6 from the starting material 8 indicate that this synthesis would be suitable for a gram-order synthesis of the powerful aromatase inhibitor 6.
The minimum-energy conformations of inhibitor 6 and its structurally related analog 4-ene-6b,19-diol 3, a weak aromatase inhibitor, 20) were determined by the MOPAC package using PM3 Hamitonian. The C-and D-rings of the steroid backbone as well as the C-17 carbonyl miety and the C-19 angular methyl group of the two diols were excellently superimposed each other (Fig. 2) . There was observed a marked difference of the orientation of the C-3, C-4, C-5, and C-6 positions between the two compounds.
Structure-activity relationship and the aromatase-catalyzed 19-oxygenation of a series of 3-deoxy C 19 steroids 23) previously revealed that there is a marked difference in the binding manner between the two parent 3-deoxy-4-ene and 5-ene steroids, 1 and 4, in the active site, and that the binding aspect of the latter is comparable to that of the natural substrate AD. The mechanistic, site-directed mutagenesis, and molecular modeling studies of aromatase 4, 5, 15, [24] [25] [26] [27] indicate that a carboxyl group of 302 Glu and 309 Asp would play a critical role in the catalytic mechanism of aromatase reaction. On the basis of these previous reports, it is likely that 4b,19-diol 6 would be anchored by hydrogen bonds between two hydroxy groups of the inhibitor and two carboxyl groups of the polar amino acid residues, 302 Glu and 309 Asp, in the active site, indicating that the orientation of a 4b,19-diol function of inhibitor 6, rather than that of the C-3, C-4, C-5, and C-6 positions, would be essential for producing thermodynamically stable enzyme-inhibitor complex in the active site. The remaining polar function of this inhibitor, the C-17 carbonyl group, also would be very important in anchoring this in the active site, as seen in the binding of the other 3-deoxy steroids.
17,18)

Experimental
Melting points were measured on a Yanagimoto melting point apparatus and are uncorrected. IR spectra were recorded on a Parkin-Elmer FT-IR 1725 spectrophotometer and 1 H-NMR spectra were obtained in CDCl 3 solution with a JEOL EX 270 (270 MHz) spectrometer using tetramethylsilane as an internal standard. Mass spectra (MS) was obtained with a JEOL JMS-DX 303 spectrometer. TLC was performed on E. Merk pre-coated with silica gel (E. Merk, 70-230 mesh). Bis(trimethylsilyl)trifluoroacetamide (BSTFA) was obtained from Tokyo Kasei Kogyo Co.
Epoxydation of 19-(tert-Butyldimethylsilyloxy)androst-4-en-17-one (8) with MCPBA MCPBA (222 mg, 1.29 mmol) was added to a solution of 4-ene steroid 8 (390 mg, 0.97 mmol) in CH 2 Cl 2 (22 ml). The reaction mixture was allowed to stirred at 4°C for 15 h, diluted with EtOAc (200 ml), washed with 10% Na 2 S 2 O 3 solution, 5% NaHCO 3 solution, and H 2 O, sequentially, and dried with Na 2 SO 4 . Evaporation of the solvent gave an oil (440 mg) which was purified by column chromatography (hexane/EtOAc) to yield two products. The less polar product was identified as 4b,5b-epoxy-19-(tertbutyldimethylsilyloxy)androstan-17-one (10) Treatment of 4,5-Epoxy Steroids 9 and 10 with HClO 4 4a,5a-Epoxide 9 and its 4b,5b-isomer 10 (150 mg, 0.36 mmol) was separately dissolved in dioxane (9 ml). 0.28 mol/l HClO 4 (1.6 ml, 0.45 mmol) was added to this solution and the mixture was stirred at room temperature for 10 h. After dilution with EtOAC (200 ml), the mixture was washed with H 2 O and dried with Na 2 SO 4 . Evaporation of the solvent gave a solid product (120 mg from 9 and 160 mg from 10). Column chromatography of the product (hexane/ EtOAc) yielded two products in each experiment. The less polar product was identified as 4b,5a,19-trihydroxyandrostan-17-one (11) (87 mg, 75% from 9 and 92 mg, 79% from 10). mp 233-235°C (from acetone). The more polar product was identified as 4a,5b,19-trihydroxyandrostan-17-one (12) (3 mg, 2.6% from 9 and 10 mg, 6.8% from 10). mp 259-261°C (from acetone). 4b b,19-Diacetoxy-5a a-hydroxyandrostan-17-one (13) A solution of 4b-ol 11 (80 mg, 0.25 mmol) in pyridine (1.3 ml) and acetic anhydride (0.6 ml) was allowed to stand at room temperature for 40 h, diluted with EtOAc (50 ml), washed with 5% HCl, 5% NaHCO 3 solution, and H 2 O, sequentially, and dried with Na 2 SO 4 . After evaporation of the solvent, a solid product Vol. 50, No. 5 4b b,19-Diacetoxyandrost-5-en-17-one (14) SOCl 2 (0.11 ml, 1.51 mmol) was added to a chilled solution of 5a-ol 13 (100 mg, 0.25 mmol) in pyridine (1.1 ml) and the mixture was stirred for 10 min at 0°C. After this time, water was added to the mixture and the product was extracted with EtOAc (100 ml). The organic layer was washed with 5% HCl, 5% NaHCO 3 solution, and water, sequentially, and dried with Na 2 SO 4 . Evaporation of the solvent yielded an oil which was purified by column chromatography (hexane/ EtOAc) to give compound 14 (192 Molecular Modeling Studies Molecular models were constructed on a Silicon Graphics IRIS 4D workstation starting from data of semiempirical molecular orbital calculations with the PM3 method (MOPAC version 6, Quantum Chemistry Program No. 455) using Insight II, version 95.0 software (BiosystemTechnologies, San Diego, CA, U.S.A.). Each compound discussed in this study was subjected to a systematic conformational analysis using CVFF force field to determine all of its minimum-energy conformations. Geometries were considered minimized when the energy change between two subsequent structures was less than 0.001 kcal/mol. Low energy conformations, of which geometries were optimized with the PM3 method, were overlapped within Insight II which uses a least squares fitting algorithm to minimize the displacement between matching atoms in the structures that are superimposed.
